{"id":168415,"date":"2025-05-19T05:46:11","date_gmt":"2025-05-19T09:46:11","guid":{"rendered":"https:\/\/44.250.171.167\/?p=168415"},"modified":"2025-05-19T05:46:11","modified_gmt":"2025-05-19T09:46:11","slug":"divis-laboratories-ltd-q4fy25-23-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q4fy25-23-rise-in-profits\/","title":{"rendered":"Divis Laboratories Ltd Q4FY25; 23% rise in Profits"},"content":{"rendered":"

 <\/p>\n

Company Overview:<\/strong><\/p>\n

Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API’s, Intermediates and Nutraceutical ingredients.<\/p>\n

Financial Results:<\/strong><\/p>\n

Divis Laboratories reported Total revenue for Q4FY25 of \u20b9 2,671 Crore up from \u20b92,382 Crore in Q4FY24, a rise of 12% y-o-y.<\/p>\n

Total Expense for Q4FY25 of \u20b91,807 Crore up from \u20b91,669 Crore in Q4FY24, a rise of 8% y-o-y.<\/p>\n

Net Profit of \u20b9662 Crore up 23% from \u20b9538 Crore in Q4FY24.<\/p>\n

Earnings per Share is \u20b924.93, up 23% from \u20b920.25 in Q4FY24.<\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

  Company Overview: Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API’s, Intermediates and Nutraceutical ingredients. Financial Results: Divis Laboratories reported Total revenue for Q4FY25 of \u20b9 2,671 Crore up from \u20b92,382 Crore in Q4FY24, a rise of 12% y-o-y. Total Expense for Q4FY25 of \u20b91,807 Crore up from \u20b91,669 Crore in Q4FY24, a […]<\/p>\n","protected":false},"author":1932,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[11776],"class_list":["post-168415","post","type-post","status-publish","format-standard","hentry","category-infographics","category-earnings","tag-active-pharmaceutical-ingredients"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":162397,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q4fy24-68-rise-in-profits\/","url_meta":{"origin":168415,"position":0},"title":"Divi’s Laboratories Ltd Q4FY24; 68% rise in Profits","author":"Divyansh_Kasana","date":"June 20, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divi's Laboratories Ltd reported Revenues for Q4FY24 of \u20b92,303.00 Crores up from \u20b91,951.00 Crore year on year, a rise of 18.04%. Total Expenses for Q4FY24 of \u20b91,669.00 Crores up from \u20b91,551.00 Crores year on\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169024,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q4fy25-23-rise-in-profits-2\/","url_meta":{"origin":168415,"position":1},"title":"Divis Laboratories Ltd Q4FY25; 23% rise in Profits","author":"Divyansh_Kasana","date":"July 7, 2025","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q4FY25 of \u20b92,585.00 Crores up from \u20b92,303.00 Crore year on year, a rise of 12.24%. Total Expenses for Q4FY25 of \u20b91,807.00 Crores up from \u20b91,669.00 Crores year on\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168307,"url":"https:\/\/alphastreet.com\/india\/dr-reddys-laboratories-ltd-q4fy25-22-rise-in-profits\/","url_meta":{"origin":168415,"position":2},"title":"Dr. Reddy’s Laboratories Ltd Q4FY25; 22% rise in Profits","author":"Divyansh_Kasana","date":"May 9, 2025","format":false,"excerpt":"Company Overview: Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr. Reddy's Laboratories reported Total revenue for Q4FY25 of \u20b9 9,050 Crore up from\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/eff747db-b47c-405d-97f0-e569811049f8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/eff747db-b47c-405d-97f0-e569811049f8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/eff747db-b47c-405d-97f0-e569811049f8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/eff747db-b47c-405d-97f0-e569811049f8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/eff747db-b47c-405d-97f0-e569811049f8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/eff747db-b47c-405d-97f0-e569811049f8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168350,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q4fy25-30-rise-in-profits\/","url_meta":{"origin":168415,"position":3},"title":"Cipla Ltd Q4FY25; 30% rise in Profits","author":"Divyansh_Kasana","date":"May 13, 2025","format":false,"excerpt":"\u00a0 Company Overview: Cipla is engaged in the Business of Pharmaceuticals. Cipla has a diversified product portfolio of 1,500+ products in 50+ dosage forms and 65 therapeutic categories. Financial Results: Cipla reported Total revenue for Q4FY25 of \u20b9 7,019 Crore up from \u20b914,932 Crore in Q4FY24, a rise of 9%\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/01fc69a0-257a-4808-8d8c-e6ccf6191eb7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/01fc69a0-257a-4808-8d8c-e6ccf6191eb7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/01fc69a0-257a-4808-8d8c-e6ccf6191eb7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/01fc69a0-257a-4808-8d8c-e6ccf6191eb7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/01fc69a0-257a-4808-8d8c-e6ccf6191eb7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/01fc69a0-257a-4808-8d8c-e6ccf6191eb7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147292,"url":"https:\/\/alphastreet.com\/india\/earnings-divis-laboratories-ltd-nse-divislab-q4fy23-results-out-total-income-fell-21-yoy\/","url_meta":{"origin":168415,"position":4},"title":"Earnings | Divis Laboratories Ltd (NSE: DIVISLAB): Q4FY23 Results Out; Total Income fell 21% YoY.","author":"Divyansh_Kasana","date":"May 25, 2023","format":false,"excerpt":"Divis Laboratories Ltd is a renowned Indian company specializing in the production and global export of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical ingredients. With a solid reputation in the pharmaceutical industry, the company has established itself as a leading manufacturer of high-quality chemicals. Divis Laboratories focuses on research, development,\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166064,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q2fy25-47-rise-in-profits\/","url_meta":{"origin":168415,"position":5},"title":"Divis Laboratories Ltd Q2FY25; 47% rise in Profits","author":"Divyansh_Kasana","date":"December 16, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q2FY25 of \u20b92,338.00 Crores up from \u20b91,909.00 Crore year on year, a rise of 22.47%. Total Expenses for Q2FY25 of \u20b91,722.00 Crores up from \u20b91,526.00 Crores year on\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/168415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=168415"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/168415\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=168415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=168415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=168415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}